Calidi Biotherapeutics CLDI Cash Flow Statement (2022-2026)

NYSE CLDI
$1.32 -0.08 (-5.71%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter) 1.46M4.16M-5.36M-7.76M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-4.04M-4.16M
Depreciation and Depletion (Quarter) 0.10M0.10M0.09M0.10M0.10M0.09M0.10M0.10M0.10M0.10M0.09M
Share-based Compensation (Quarter) 1.47M1.06M4.33M1.43M1.08M1.11M4.46M0.89M0.75M0.69M0.63M0.61M0.52M0.53M0.45M0.40M
Gains from Investment Securities (Quarter) -2.09M-4.03M-0.46M-0.14M-0.09M1.28M
Cash from Operations (Quarter) -0.47M-0.27M-8.60M-3.88M-3.11M-5.17M-13.52M-5.19M-3.83M-5.49M-4.95M-5.42M-7.13M-4.88M-4.24M-5.05M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.12M0.20M0.02M0.20M-0.28M0.02M0.02M0.01M0.00M
Amortization of Deferred Charges (Quarter) 0.09M0.25M0.26M0.27M0.27M0.28M0.29M0.29M0.30M
Depreciation & Amortization (CF) (Quarter) 0.10M0.10M0.09M0.10M0.10M0.09M0.10M0.10M0.10M0.39M0.09M0.10M0.10M1.35M0.10M
Change in Working Capital
Change in Account Payables (Quarter) -0.00M536.001.56M0.06M0.02M-1.69M-5.98M1.49M0.97M0.17M-0.60M-1.17M-0.75M0.02M-0.19M-0.40M
Change in Accured Expenses (Quarter) -0.02M0.02M2.00M-0.22M0.24M1.25M-0.79M0.58M-0.39M-0.71M-0.19M-0.57M-1.69M0.24M0.26M-0.81M
Other Working Capital Changes (Quarter) 0.15M0.28M0.28M1.30M0.35M-1.57M-0.01M-0.47M0.25M0.32M-0.16M-0.12M0.00M
Investing Activities
Capital Expenditures (Quarter) 0.16M0.25M-0.22M0.49M0.07M0.01M0.01M0.01M0.01M0.06M0.03M0.03M
Cash from Investing Activities (Quarter) -0.33M-0.16M-0.14M-0.24M-0.06M-0.04M-0.01M-0.01M-0.01M-0.01M-0.06M-0.03M-0.08M
Financing Activities
Other financing activities (Quarter) -0.06M0.07M0.16M1.26M0.66M0.16M-0.16M0.50M-1.28M0.30M-0.30M0.72M-0.72M
Cash from Financing Activities (Quarter) 7.77M4.32M3.79M6.58M21.64M-2.96M3.01M5.20M6.05M13.11M8.11M-0.47M9.48M0.34M
Additional items
Exchange Rate Effect (Quarter) 0.01M0.02M-0.02M0.02M-0.01M-0.03M0.02M0.01M
Change in Cash (Quarter) -0.47M-0.27M-1.20M0.29M0.55M1.15M8.08M-8.20M-0.81M-0.31M1.06M7.69M0.97M-5.40M5.21M-4.78M
Free Cash Flow (Quarter) -0.47M-0.27M-8.60M-4.04M-3.36M-4.95M-14.01M-5.26M-3.84M-5.49M-4.95M-5.43M-7.14M-4.94M-4.26M-5.08M
Net Cash Flow (Quarter) -0.47M-0.27M-1.17M0.28M0.55M1.16M8.06M-8.18M-0.82M-0.29M1.09M7.68M0.97M-5.41M5.21M-4.79M